Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.62 Analyst target: $6.98 Upside: 1028.90%
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
See the full interactive analysis & chart →Informational only — not investment advice.